ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670289; 2) Community: the network communities that were significantly associated with the response to NSC 670289; 3) Molecule: the relationships between components within communities and NSC 670289; 4) MDR: the compounds that were significantly associated with the NSC 670289.

NSC Compound Enrichment Correlation
NSC 710904 Null 0.0382675857669587 0.42155037
NSC 681634 Camptothecin Derivative 0.0382675857669588 0.077878183
NSC 716178 Null 0.0382675857669588 0.0085153645
NSC 745957 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide 0.0382675857669588 0.2434081
NSC 84145 Null 0.0382675857669588 0.21545788
NSC 119875 Cisplatin 0.0414190425892865 0.2249516
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0414190425892865 0.34088531
NSC 295500 Camptothecin Derivative 0.0414190425892865 0.2053609
NSC 376739 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0414190425892865 0.13503824
NSC 605583 3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.0414190425892865 -0.087283798
Total:80  Current:67    [First] [Prev] [Next] [Last]